Product catalog antigen listed by alphabetic starting with G
| Items 1 to 100 of 979 total | 10 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| 10-288-22422F | G patch domain and KOW motifs variant antigen | ||||||
| Human | Purified | 90% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22422F-50 | G patch domain and KOW motifs variant antigen | ||||||
| Human | Purified | 90% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| GTX25006 | G Protein alpha Inhibitor 1+2 peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| 10-288-21973F | G protein beta subunit-like antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-21973F-50 | G protein beta subunit-like antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| GTX82964 | G Protein-Coupled Receptor GPR30 blocking peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX78412 | G Protein-Coupled Receptor GPRC5C blocking peptide antigen | ||||||
| Purified | 50 µl / --- | ||||||
| GeneTex Inc. | |||||||
| GTX29692 | G-CSF protein antigen | ||||||
| 10 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX29752 | G-CSF protein antigen | ||||||
| Purified | 10 µg / --- | ||||||
| GeneTex Inc. | |||||||
| H00002354-Q01-10 | G0/G1 switch regulatory protein 3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002354-Q01-25 | G0/G1 switch regulatory protein 3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00050486-P01-02 | G0S2 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00050486-P01-10 | G0S2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00050486-P01-25 | G0S2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002537-P01-10 | G1P3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002537-P01-25 | G1P3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055632-Q01-10 | G2/M phase-specific E3 ubiquitin-protein ligase antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055632-Q01-25 | G2/M phase-specific E3 ubiquitin-protein ligase antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002547-P01-10 | G22P1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002547-P01-25 | G22P1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010146-Q01-10 | G3BP antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010146-Q01-25 | G3BP antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009908-Q01-10 | G3BP2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009908-Q01-25 | G3BP2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002548-Q01-10 | GAA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002548-Q01-25 | GAA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002549-Q01-10 | GAB1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002549-Q01-25 | GAB1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011337-Q01-10 | GABARAP antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011337-Q01-25 | GABARAP antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011345-Q01-10 | GABARAPL2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011345-Q01-25 | GABARAPL2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002550-Q01-10 | GABBR1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002550-Q01-25 | GABBR1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002551-P01-10 | GABPA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002551-P01-25 | GABPA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002551-Q01-10 | GABPA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002551-Q01-25 | GABPA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002553-Q01-10 | GABPB2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002553-Q01-25 | GABPB2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002556-P01-10 | GABRA3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002556-P01-25 | GABRA3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002560-Q01-10 | GABRB1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002560-Q01-25 | GABRB1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002562-Q01-10 | GABRB3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002562-Q01-25 | GABRB3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002564-P01-10 | GABRE antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002564-P01-25 | GABRE antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002571-P01-10 | GAD1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002571-P01-25 | GAD1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002571-P02-10 | GAD1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002571-P02-25 | GAD1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001647-Q01-10 | GADD45A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001647-Q01-25 | GADD45A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010912-P01-10 | GADD45G antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010912-P01-25 | GADD45G antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| SA6041 | GAGA POZ Domain antigen | ||||||
| Drosophila | Purified | >95% | E. coli | 0.1 mg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| SA6041X | GAGA POZ Domain antigen | ||||||
| Drosophila | Purified | >95% | E. coli | 0.5 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| H00084057-P01-10 | GAJ antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084057-P01-25 | GAJ antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002580-P01-10 | GAK antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002580-P01-25 | GAK antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002580-Q01-10 | GAK antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002580-Q01-25 | GAK antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051083-P01-10 | GAL antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051083-P01-25 | GAL antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009514-Q01-10 | GAL3ST1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009514-Q01-25 | GAL3ST1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22113F | Galactokinase antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22113F-50 | Galactokinase antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00027087-Q01-10 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00027087-Q01-25 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026229-Q01-10 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026229-Q01-25 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002581-Q01-10 | GALC antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002581-Q01-25 | GALC antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002582-P01-10 | GALE antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002582-P01-25 | GALE antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003956-Q02-10 | Galectin-1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003956-Q02-25 | Galectin-1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA227 | Galectin-1 antigen | ||||||
| Human | >97% | E. coli | 10 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA227X | Galectin-1 antigen | ||||||
| Human | >97% | E. coli | 50 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA274 | Galectin-3 antigen | ||||||
| Human | >97% | E. coli | 10 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA274X | Galectin-3 antigen | ||||||
| Human | >97% | E. coli | 50 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| 10-288-22418F | Galectin-3-binding protein antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22418F-50 | Galectin-3-binding protein antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00003960-Q01-10 | Galectin-4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003960-Q01-25 | Galectin-4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003965-Q01-10 | Galectin-9 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003965-Q01-25 | Galectin-9 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002584-P01-10 | GALK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002584-P01-25 | GALK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002584-Q01-10 | GALK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002584-Q01-25 | GALK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002585-P01-10 | GALK2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002585-P01-25 | GALK2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002585-Q01-10 | GALK2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002585-Q01-25 | GALK2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051363-P01-10 | GALNAC4S-6ST antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051363-P01-25 | GALNAC4S-6ST antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| Items 1 to 100 of 979 total | 10 Page(s): |

